Sorrento Therapeutics (SRNE) Stock Forecast for 2023 – 2026. Sell or Buy Prediction







Trading Penny Stocks for Profit: Expert Insights and Practical Advice

February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice

For aspiring traders and seasoned investors alike, the enticing appeal of penny stocks can be likened to voyaging across the vast oceans, discovering…
Getting A Kredittkort Norge Approval Isn’t Difficult

February 8, 2024 Getting A Kredittkort Norge Approval Isn’t Difficult

If you meet the conditions, you can open an account for checking in Norway. However, it will be much easier and more convenient…
How to Understand Social Security: 6 Legal & Financial Tips

January 25, 2024 How to Understand Social Security: 6 Legal & Financial Tips

Understanding social security can seem overwhelming, but it’s an important part of financial planning, particularly for retirement. The following 6 legal and financial…
Finding Energy Plans with Billig Strøm Rates

January 10, 2024 Finding Energy Plans with Billig Strøm Rates

It can be overwhelming to decide on the best plan when in a state where electricity is deregulated. The number of providers is…

Sorrento Therapeutics (SRNE) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: February 27, 2024 (17:55)

Sector: Healthcare

The share price of Sorrento Therapeutics, Inc. (SRNE) now

Latest session on the 27th of February for
Sorrento Therapeutics, Inc. is negative
Trading Volume: 117697
Open: 0.03 /  High: 0.05 /  Low: 0.026
What analysts predict: $
52-week High/Low: $ / $

50/200 Day Moving Average: $ / $

This figure corresponds to the Average Price over the previous 50/200 days. For Sorrento Therapeutics stocks, the 50-day moving average is the support level today.

For Sorrento Therapeutics stocks, the 200-day moving average is the support level today.

Are you interested in Sorrento Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Sorrento Therapeutics stock price in 2024, 2025, 2026, 2027, 2028. How much will one Sorrento Therapeutics share be worth in 2024 - 2028?

When should I take profit in Sorrento Therapeutics stock? When should I record a loss on Sorrento Therapeutics stock? What are analysts' forecasts for Sorrento Therapeutics stock? What is the future of Sorrento Therapeutics stock? We forecast Sorrento Therapeutics stock performance using neural networks based on historical data on Sorrento Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Sorrento Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Sorrento Therapeutics shares. This happens once a day.


Historical and forecast chart of Sorrento Therapeutics stock

The chart below shows the historical price of Sorrento Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Sorrento Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Sorrento Therapeutics, Inc., a clinical stage Biopharma company, develops treatments for cancer, autoimmune, inflammatory and neurodegenerative diseases. She operates in two segments – Sorrento Therapeutics and Scilex. The company provides cancer therapists through the use of a proprietary r-monoclonal antibody antibody library and targeted delivery conditions that include chimeric antigen receptor T-cell therapy (car-T), dimeric antigen receptor T-cell therapy, and antibody-drug conjugates as well as bispecific antibody approaches. It also offers Sofusa, a drug delivery technology that delivers biological substances directly to the lymphatic system. In addition, the company’s clinical programs include anti-CD38 CAR-T therapy for the treatment of multiple myeloma as well as amyloidosis and graft versus host diseases. In addition, he is developing resiniferatoxin, a neopioid-based TRPV1 agonist neurotoxin for the treatment of advanced cancer and osteoarthritis of knee pain; and ZTlido, a lidocaine delivery system for the treatment of postherpetic neuralgia. In addition, the company is developing SEMDEXA, an injectable viscous gel formulation that is a Phase III trial for the treatment of sciatica, a pathology of low back pain; and SP-103, an investigational non-aqueous lidocaine topical system in clinical development for chronic low back pain. She has various collaborations with SmartPharm Therapeutics Inc. to develop a gene-encoded vaccine antibody to protect against COVID-19; Celularity, Inc. to initiate a Phase I / II clinical trial with up to 86 COVID-19 patients; and the Mount Sinai Health System to develop COVI-SHIELD, an antibody therapy targeting SARS-CoV-2 infection, and a Research Trials Agreement with the University of Texas Medical Branch at Galveston for preclinical testing of Sorrento’s COVID-19 therapeutic product candidates. The company was founded in 2006 and is based in San Diego, California.

Sorrento Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
Feb 29 0.03 0.03 0.03 7.29
Mar 01 0.03 0.03 0.03 6.29
Mar 02 0.03 0.03 0.03 4.86
Mar 03 0.03 0.03 0.03 7.89
Mar 04 0.03 0.03 0.03 6.78
Mar 05 0.03 0.03 0.03 4.96
Mar 06 0.03 0.03 0.03 7.64
Mar 07 0.03 0.03 0.03 6.22
Mar 08 0.03 0.03 0.03 9.08
Mar 09 0.03 0.03 0.03 8.45
Mar 10 0.03 0.03 0.03 5.05
Mar 11 0.03 0.03 0.03 2.74
Mar 12 0.03 0.03 0.03 5.55
Mar 13 0.03 0.03 0.03 5.98
Mar 14 0.03 0.03 0.03 7.91
Mar 15 0.03 0.03 0.03 5.86
Mar 16 0.03 0.03 0.03 3.37
Mar 17 0.03 0.03 0.03 3.73
Mar 18 0.03 0.03 0.03 7.13
Mar 19 0.03 0.03 0.03 5.72
Mar 20 0.03 0.03 0.03 4.15
Mar 21 0.03 0.03 0.03 4.27
Mar 22 0.03 0.03 0.03 6.83
Mar 23 0.03 0.03 0.03 5.01
Mar 24 0.03 0.03 0.03 6.15
Mar 25 0.03 0.03 0.03 4.94
Mar 26 0.03 0.03 0.03 7.58
Mar 27 0.03 0.03 0.03 6.43
Mar 28 0.03 0.03 0.03 6.78
Mar 29 0.03 0.02 0.03 7.26

Sorrento Therapeutics Daily Price Targets


Sorrento Therapeutics Stock Forecast 02-29-2024.

Forecast target price for 02-29-2024: $0.03.
Negative dynamics for Sorrento Therapeutics shares will prevail with possible volatility of 6.792%.
Pessimistic target level: 0.03
Optimistic target level: 0.03

Sorrento Therapeutics Stock Forecast 03-01-2024.

Forecast target price for 03-01-2024: $0.03.
Negative dynamics for Sorrento Therapeutics shares will prevail with possible volatility of 5.915%.
Pessimistic target level: 0.03
Optimistic target level: 0.03

Sorrento Therapeutics Stock Forecast 03-02-2024.

Forecast target price for 03-02-2024: $0.03.
Negative dynamics for Sorrento Therapeutics shares will prevail with possible volatility of 4.637%.
Pessimistic target level: 0.03
Optimistic target level: 0.03

Sorrento Therapeutics Stock Forecast 03-03-2024.

Forecast target price for 03-03-2024: $0.03.
Positive dynamics for Sorrento Therapeutics shares will prevail with possible volatility of 7.317%.
Pessimistic target level: 0.03
Optimistic target level: 0.03

Sorrento Therapeutics Stock Forecast 03-04-2024.

Forecast target price for 03-04-2024: $0.03.
Positive dynamics for Sorrento Therapeutics shares will prevail with possible volatility of 6.346%.
Pessimistic target level: 0.03
Optimistic target level: 0.03

Sorrento Therapeutics Stock Forecast 03-05-2024.

Forecast target price for 03-05-2024: $0.03.
Positive dynamics for Sorrento Therapeutics shares will prevail with possible volatility of 4.726%.
Pessimistic target level: 0.03
Optimistic target level: 0.03

SRNE (SRNE) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Mar. 0.12 0.10 0.13 18.14
Apr. 0.13 0.12 0.15 21.47
May. 0.13 0.12 0.14 18.17
Jun. 0.13 0.11 0.15 21.91
Jul. 0.11 0.10 0.12 18.55
Aug. 0.12 0.11 0.14 23.17
Sep. 0.12 0.12 0.14 15.66
Oct. 0.13 0.12 0.14 16.60
Nov. 0.13 0.11 0.14 22.68
Dec. 0.15 0.13 0.17 22.85

Sorrento Therapeutics forecast for this year


Sorrento Therapeutics Stock Prediction for Mar 2024

An uptrend is forecast for this month with an optimal target price of $0.116305. Pessimistic: $0.10. Optimistic: $0.13


Sorrento Therapeutics Stock Prediction for Apr 2024

An uptrend is forecast for this month with an optimal target price of $0.130669. Pessimistic: $0.12. Optimistic: $0.15


Sorrento Therapeutics Stock Prediction for May 2024

An uptrend is forecast for this month with an optimal target price of $0.134145. Pessimistic: $0.12. Optimistic: $0.14


Sorrento Therapeutics Stock Prediction for Jun 2024

An downtrend is forecast for this month with an optimal target price of $0.131596. Pessimistic: $0.11. Optimistic: $0.15


Sorrento Therapeutics Stock Prediction for Jul 2024

An downtrend is forecast for this month with an optimal target price of $0.113344. Pessimistic: $0.10. Optimistic: $0.12


Sorrento Therapeutics Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $0.124542. Pessimistic: $0.11. Optimistic: $0.14


Sorrento Therapeutics Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $0.124779. Pessimistic: $0.12. Optimistic: $0.14


Sorrento Therapeutics Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $0.126438. Pessimistic: $0.12. Optimistic: $0.14


Sorrento Therapeutics Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $0.129801. Pessimistic: $0.11. Optimistic: $0.14


Sorrento Therapeutics Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $0.151504. Pessimistic: $0.13. Optimistic: $0.17



Sorrento Therapeutics (SRNE) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 0.14 0.13 0.15 9.81
Feb 0.13 0.12 0.13 10.43
Mar 0.14 0.13 0.15 13.21
Apr 0.17 0.15 0.19 17.84
May 0.15 0.15 0.17 16.13
Jun 0.16 0.14 0.18 24.65
Jul 0.16 0.15 0.19 22.10
Aug 0.15 0.14 0.17 19.82
Sep 0.17 0.16 0.19 15.68
Oct 0.14 0.13 0.16 18.25
Nov 0.12 0.11 0.14 19.12
Dec 0.12 0.11 0.13 12.80

Sorrento Therapeutics (SRNE) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 0.11 0.10 0.12 9.87
Feb 0.13 0.12 0.15 20.42
Mar 0.14 0.12 0.16 25.28
Apr 0.16 0.15 0.17 14.81
May 0.15 0.13 0.17 25.24
Jun 0.16 0.14 0.17 16.09
Jul 0.16 0.14 0.18 21.27
Aug 0.15 0.14 0.15 9.65
Sep 0.13 0.12 0.15 23.69
Oct 0.16 0.15 0.17 13.09
Nov 0.15 0.15 0.17 13.49
Dec 0.15 0.14 0.17 19.96

Sorrento Therapeutics (SRNE) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 0.15 0.14 0.16 17.76
Feb 0.15 0.13 0.17 21.85
Mar 0.17 0.15 0.19 22.04
Apr 0.16 0.15 0.18 15.28
May 0.17 0.15 0.19 19.99
Jun 0.18 0.17 0.19 11.12
Jul 0.17 0.16 0.18 10.23
Aug 0.16 0.15 0.18 17.20
Sep 0.16 0.14 0.16 12.24
Oct 0.17 0.15 0.18 15.99
Nov 0.19 0.17 0.22 20.78
Dec 0.21 0.18 0.22 18.29

Sorrento Therapeutics (SRNE) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 0.21 0.18 0.23 21.53
Feb 0.21 0.19 0.23 18.57
Mar 0.23 0.20 0.25 22.53
Apr 0.25 0.22 0.28 20.30
May 0.28 0.24 0.31 21.38
Jun 0.24 0.22 0.27 18.53
Jul 0.27 0.24 0.30 20.16
Aug 0.27 0.25 0.31 21.19
Sep 0.25 0.24 0.29 14.98
Oct 0.25 0.22 0.27 20.23
Nov 0.26 0.22 0.29 24.15
Dec 0.30 0.27 0.32 17.71

Sorrento Therapeutics information and performance

Sorrento Therapeutics Address

N/A

Market Capitalization: N/A $

Market capitalization of the Sorrento Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of SRNE shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of Sorrento Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.